Search Results - "Rodriguez Lorenc, Karen Cristina"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Ribociclib (LEE011) and letrozole in estrogen receptor-positive (ER+), HER2-negative (HER2–) advanced breast cancer (aBC): Phase Ib safety, preliminary efficacy and molecular analysis

    Ribociclib (LEE011) and letrozole in estrogen receptor-positive (ER+), HER2-negative (HER2–) advanced breast cancer (aBC): Phase Ib safety, preliminary efficacy and molecular analysis by Juric, Dejan, Munster, Pamela N., Campone, Mario, Ismail-Khan, Roohi, García-Estevez, Laura, Hamilton, Erika Paige, Becerra, Carlos, De Boer, Richard H., Hui, Rina, Goncalves, Anthony, Wang, Yingbo, Dhuria, Shyeilla V., Kalimi, Ghulam H., Rodriguez Lorenc, Karen Cristina, Mayer, Ingrid A.

    Published in Journal of clinical oncology (20-05-2016)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Ribociclib (RIB) + fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from MONALEESA-3

    Ribociclib (RIB) + fulvestrant (FUL) in postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC): Results from MONALEESA-3 by Slamon, Dennis J., Neven, Patrick, Chia, Stephen K. L., Im, Seock-Ah, Fasching, Peter A., DeLaurentiis, Michelino, Petrakova, Katarina, Bianchi, Giulia Valeria, Esteva, Francisco J., Martin, Miguel, Pivot, Xavier, Vidam, Gena, Wang, Yingbo, Rodriguez Lorenc, Cristina Karen, Miller, Michelle Kristine, Taran, Tanya, Jerusalem, Guy Heinrich Maria

    Published in Journal of clinical oncology (20-05-2018)
    “…Abstract only…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: